Brief: Imricor Medical Systems Receives Approval To Commence Visabl-Vt Trial In Germany
26/09/2023 02:55
Sept 26 (Reuters) - Imricor Medical Systems Inc
IMR.AX :
* RECEIVES APPROVAL TO COMMENCE VISABL-VT TRIAL IN GERMANY
Source text for Eikon: ID:nASX3hBZmg
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion